Lawsuits filed by the attorneys general in Massachusetts and New York have brought to light the extensive involvement of the Sackler family, which owns OxyContin maker Purdue Pharma, in the opioid crisis, The New York Times reports.
Purdue Pharma, which makes OxyContin, has agreed to pay $270 million to resolve a lawsuit filed by Oklahoma’s attorney general, The Wall Street Journal reports. The majority of the settlement will fund a national opioid addiction center.
A new study finds a decrease of more than 50 percent in monthly opioid prescribing for new patients. However some doctors continue to write many opioid prescriptions, while others are not writing any, HealthDay reports.
Teens prescribed opioids after surgery are almost twice as likely to use the drugs long-term if they have a family member who has filled opioid prescriptions for four months or more over the past year, a new study finds.
The U.S. Food and Drug Administration (FDA) has issued a new round of warnings and advisory letters to makers of dietary supplements, telling them not to falsely claim their products cure, prevent or treat serious diseases. Last year the FDA and the Federal Trade Commission sent warning letters to makers and distributors of 12 products sold as treatments for opioid addiction and withdrawal.